Retatrutide (20mg)
Original price was: $399.99.$199.99Current price is: $199.99.Retatrutide represents the next generation of metabolic peptide research. As a first-in-class triple hormone receptor agonist targeting GIP, GLP-1, and glucagon pathways, Retatrutide has gained major attention for its powerful body-composition research profile.
In a published Phase 2 obesity trial, Retatrutide demonstrated dose-dependent weight reduction, with the highest studied dose reaching up to 24.2% average body-weight reduction at 48 weeks.
More recently, Lilly’s Phase 3 TRIUMPH-1 topline results reported average reductions of 19.0% at 4 mg, 25.9% at 9 mg, and 28.3% at 12 mg over 80 weeks, with 45.3% of participants on 12 mg achieving at least 30% body-weight reduction.
Body-composition research has also shown significant reductions in total fat mass versus placebo and dulaglutide, supporting Retatrutide’s position as one of the most exciting investigational compounds in modern fat-loss and metabolic research.
SSA Peptides offers Retatrutide strictly for For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.

